This inventor holds 10 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1980-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1984
Title: The Innovations of George E Albers-Schonberg
Introduction
George E Albers-Schonberg is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of microbiology and pharmacology, holding a total of 10 patents. His work primarily focuses on the development of compounds with medicinal properties, particularly in the areas of antiparasitic and hypocholesteremic treatments.
Latest Patents
One of his latest patents involves a strain of Streptomyces for producing antiparasitic compounds. This innovation describes novel compounds produced by the fermentation of a nutrient medium with the previously undescribed microorganism Streptomyces avermitilis. These compounds, generically referred to as C-076, exhibit significant parasiticidal activity and can be utilized in compositions for oral or parenteral administration to animals for the prevention and treatment of parasitic infections. Another recent patent focuses on hypocholesteremic fermentation products and their preparation process. This patent details substances isolated after cultivating a microorganism from the genus Aspergillus in a culture medium, resulting in compounds that form a class of highly active hypocholesteremic and hypolipemic medicaments.
Career Highlights
George E Albers-Schonberg is currently associated with Merck & Company, Inc., where he continues to innovate and contribute to the field of pharmaceuticals. His extensive research and development efforts have led to advancements in treatments that address significant health issues.
Collaborations
Throughout his career, Albers-Schonberg has collaborated with esteemed colleagues, including Richard L Monaghan and Alfred W Alberts. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
George E Albers-Schonberg's contributions to the field of microbiology and pharmacology are noteworthy. His patents reflect a commitment to developing effective treatments for parasitic infections and cholesterol management. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile